# What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more - NBC News

## Metadata
| Field | Value |
|-------|-------|
| Source | NBC News |
| URL | https://news.google.com/rss/articles/CBMitAFBVV95cUxQSnRDODZIZFduWE1oc0xWWTFsTDNWUFh4ZEc1Vk91QVFaU3BKbGgwSEdLM3FCSk15TENFWHphekxmQTh0cHlwLWNJVVZoWTJxZGxuTGg3ZXBKS3kzUV9jQ1pkSkZPNGlVZVg4MUk2bUoza0RvNVVUNk5ybGJ4SmZjdUF4NE85aDFxUlBqU01JODhwUzE4alJweXRhZnV4c1NOVUM0ZnFuT041YjVBRXJmYmpXcmrSAVZBVV95cUxNSGh5S3JQVU1BSllxU0kwWWg4WW5UdWQwSFJZQk5HM3hucEFuZmtHYlZZWU1fUVdEc3BNeWV6LXJibEJ0RzlnRHhOMjRhVGZ5dk5BZkFiZw?oc=5&hl=en-US&gl=US&ceid=US:en |
| Scraped | 2026-01-04 07:00 |
| Category | GLP-1 |
| Relevance | 8/10 |
| Signal | bull |

## Investment Summary
Article discusses emerging market dynamics for GLP-1 weight loss medications, highlighting potential pricing shifts and oral medication developments for obesity treatment in 2026.

## Key Entities
Novo Nordisk, Eli Lilly, NBC News

## Dollar Amounts
None mentioned

---

## Article Content

*Full content could not be extracted. Visit URL for details.*

---

#healthcare-news #glp-1 #auto-scraped
